Emergent Biosolutions EBS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $75.9M-45.6% | $139.5M+206% | -$131.6M+31.0% | ||
| $93.9M-2.0% | $95.8M-2.5% | $98.3M-3.0% | $101.3M-4.7% | $106.3M-2.3% | ||
| $16.6M+2.5% | $16.2M+6.6% | $15.2M+19.7% | $12.7M-6.6% | $13.6M-24.4% | ||
| $150.3M-13.1% | $172.9M— | —— | —— | —— | ||
| $12.6M-8.7% | $13.8M+19.0% | $11.6M-17.1% | $14M-10.8% | $15.7M-31.4% | ||
| —— | —— | —— | $217.3M+11.2% | $195.5M+56.2% | ||
| $33.9M+36.1% | $24.9M+57.6% | $15.8M+129% | $6.9M— | —— | ||
| -$147.6M-8.1% | -$136.6M-502% | -$22.7M+87.9% | -$187.1M+19.2% | -$231.6M-21.6% | ||
| —— | —— | —— | $200M+171% | $73.8M+1,310% | ||
| $141.1M-13.2% | $162.5M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Emergent Biosolutions generate?
- Emergent Biosolutions (EBS) generated $150.3M in operating cash flow over the trailing twelve months.
- What is Emergent Biosolutions's free cash flow?
- After $12.6M of capital expenditures, Emergent Biosolutions's free cash flow was $141.1M over the trailing twelve months, up 310.0% year over year.
- Where does Emergent Biosolutions's cash flow data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
